PUBLIC COMPANY
saveCelltrion Inc
updated 2mo ago
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year.
community read0 votes
🐶 often sniffed alongside
top 8pipeline
12
marketed
5
phase 3
1
catalysts ytd
2
approvals ytd
2
recalls ytd
0
Pipeline(12)
pipeline depth12 products
2Preclinical1Phase 11Phase 21Phase 35Marketed2Unknown
Marketed
AVTOZMA
MarketedEYDENZELT
MarketedOSENVELT
MarketedSTEQEYMA
MarketedYUFLYMA
Phase 3ocrelizumab biosimilar
Relapsing Remitting Multiple Sclerosis (RRMS)
Phase 2regdanvimab
Coronavirus Disease 2019 (COVID-19)
Phase 1PBXCT-02
Bladder Cancer
PreclinicalCTP-45
Autoimmune Disorders
PreclinicalCTP-68
Autoimmune Disorders
drugOMLYCLO
drugTRUXIMA
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that